Optimising treatment decisions: why speed of effect matters in ATTR-CM

28 August 2026 (12:34 - 12:52)

Organised by:

Slides

Sign in to view the resources

About the speakers

Doctor Laura Obici

I.R.C.C.S. San Matteo Polyclinic, Pavia (Italy)

Professor Carsten Tschoepe

German Heart Centre Berlin, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail

Introduction

Professor C. Tschoepe (Berlin, DE)

Presentation thumbnail

Optimising treatment decisions: the clinical relevance of strength of effect in ATTR-CM

Doctor L. Obici (Pavia, IT) Doctor J. Gillmore (Greater London, GB)

Presentation thumbnail

Optimising treatment decisions: personalising ATTR-CM treatment in real-world practice

Doctor S. Cuddy (Boston, US) Doctor P. Garcia-Pavia (Majadahonda, ES)

Presentation thumbnail

Closing remarks

Professor C. Tschoepe (Berlin, DE)

Access the full session

Session thumbnail

Then and now: reflections on the transformation of ATTR-CM care

The Event

Event poster

ESC Congress 2026

28 August 2026 12:34 CET

You may be interested in

Congress Presentation

Changing the trajectory: interventions to mitigate risk

30 August 2026

Congress Presentation

Turning data into decisions: insights from trials and real-world experience in ATTR-CM

12 December 2025

Congress Presentation

Acoramidis improves serum TTR levels in patients with wild-type or variant transthyretin amyloid cardiomyopathy - results from ATTRibute-CM

20 May 2025

Congress Session

Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing

28 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources